About 6,000 healthcare industry executives, scientists, engineers, physicians and investors from 45 countries are expected at the Biomed Israel life science and health-tech conference in Tel Aviv, May 16-18.
This is the 21st consecutive edition of Biomed Israel, billed as the largest meeting venue for healthcare professionals from Israel with their international colleagues and partners.
The three-day event presents opportunities for business networking aimed at joint projects that can shape the future of healthcare. Hundreds of Israeli life-science companies will exhibit their innovative products.
Fifteen topics will be explored by the speakers and panelists in these sessions:
- Longevity – How to Complete the Centenarian Decathlon
- Do We Know Enough About the Brain to Treat Neurological Disorders?
- Are Cancer Therapeutics Fulfilling the Promise?
- Can We Successfully Diagnose and Guide Patients’ Optimal Cancer Treatment?
- Optimizing the Interaction of AI and Biopharma
- Facts and Myths on Ex-Liver Delivery and New Horizons to Cure Rare Disorders
- Who Owns Health Decisions? The Changing Dynamics of Patient-Physician Relationships in the Digital Health Revolution
- Robots Dancing with Humans in Healthcare Systems and Homes
- Are Medical Devices Still Relevant in the Context of New Biology?
- Let Food Be Thy Medicine and Medicine Be Thy Food
- How to Make Academic Translation Medicine Replicable and Relevant
- Bio Convergence: Everything That Rises Must Converge
- High-Pace Innovation in Dermatology & Medical Aesthetics
- Ophthalmology, from R&D to Commercialization
- Navigating Global Collaborations in Times of Uncertainty: Can We Turn Challenges into Growth Opportunities?
The conference is co-chaired by Ruti Alon, founder and CEO of Medstrada Venture Capital; Ora Dar, PhD, senior expert on medical sciences and health innovation; and Dr. Nissim Darvish, managing partner of Eliraz Ventures.
“The first and foremost objective of Biomed Israel is to boost collaborations between the innovative health-tech ecosystem in Israel and the global life science industry,” said Alon.
“Senior executives and delegations from multinationals, big pharma, medical devices, tech giants and international investors in the health industry come to Israel each May to ‘shop for’ innovation in the field, in search for creative solutions, products and technologies, and the next big thing.”
She noted that this year’s conference includes practical workshops in the fields of regulation and reimbursement.
“We are also focusing on prevention and looking into the future of health innovation, in the longevity and precision nutrition tracks, for example, and have included a plenary talk on quantum computing,” she added.